A phase II study of laquinimod in Crohn's disease.

A phase II study of laquinimod in Crohn's disease.

Item
http://www.wikidata.org/entity/Q35891861
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsEvolving Concepts in Phases I and II Drug Development for Crohn's Disease.S100-alarmins: potential therapeutic targets for arthritis.Emerging therapeutic targets and strategies in Crohn's disease.Immunomodulators for the treatment of Crohn's disease in adults: optimal use and prospects for future drug treatments.Will novel oral formulations change the management of inflammatory bowel disease?Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease.Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model.Next generation of small molecules in inflammatory bowel disease.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.
P2860

A phase II study of laquinimod in Crohn's disease.

Item
http://www.wikidata.org/entity/Q35891861
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A phase II study of laquinimod in Crohn's disease.
@ast
A phase II study of laquinimod in Crohn's disease.
@en
type
label
A phase II study of laquinimod in Crohn's disease.
@ast
A phase II study of laquinimod in Crohn's disease.
@en
prefLabel
A phase II study of laquinimod in Crohn's disease.
@ast
A phase II study of laquinimod in Crohn's disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A phase II study of laquinimod in Crohn's disease.
@en
P2093
P2860
P304
P31
P356
10.1136/GUTJNL-2014-307118
P407
P433
P478
P50
P577
P5875
P698
P921
P932